International Immunology, Vol. 6, No. 1, pp. 157-167,January 1994
© 1994 Japanese Society for Immunology
Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-
in vivo
Departments of inflammation/Autoimmune Diseases Nutley, NJ 07110, USA
1 Toxicology, Hoffmann-La Roche Inc. Nutley, NJ 07110, USA
2 Genetics Institute Inc. Cambridge, MA 02140, USA
Correspondence to: Correspondence to: M. K. Gately
2 Is a heterodlmerlc cytoklne that has been shown to enhance natural killer (NK) and cytotoxic T lymphocyte (CTL) responses, and to induce IFN-
production in vitro. In this study, we have examined the effects in vivo of administering purified murine rlL-12 to normal mice. Dally injections of riL-12 I.p. (1 ng to 10 µg/day) caused dose-dependent enhancement of NK cell lytic activity in the spleens and livers of treated mice. Histologlc examination of the livers of IL-12-treated mice revealed focal mononuclear cell infiltrates, and flow cytometry studies indicated that the livers of IL-12-treated mice contained increased numbers of NK cells, CD8+ T cells, and monocytes. Liver and splenic lymphold cells from IL-12-treated mice, unlike liver and splenic lymphoid cells from control mice, spontaneously secreted IFN- in vitro, suggesting that they had been induced by IL-12 to produce IFN- in vivo. Consistent with this, IFN- could be detected in the serum of IL-12-treated mice. In mice which had been immunized by footpad injection of allogenelc splenocytes, dally administration of rlL-12 I.p. was shown to enhance the specific CTL response in the draining lymph nodes. Thus, these studies demonstrate that IL-12 can enhance NK and CTL activity and induce IFN- production in vivo, as well as in vitro, and suggest possible mechanisms by which IL-12 may exert therapeutic effects in the treatment of some tu more and infectious diseases.
Keywords: ytic T lymphocytes, immunotherapy, interferon, mterleukin, natural killer cells
Received 20 August 1993, accepted 7 October 1993.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Siddiqui, C.-Y. Li, S. M. LaRue, J. M. Poulson, P. R. Avery, A. F. Pruitt, X. Zhang, R. L. Ullrich, D. E. Thrall, M. W. Dewhirst, et al. A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas Mol. Cancer Ther., January 1, 2007; 6(1): 380 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-c. Chen, R. Wang, X. Zhao, Y.-q. Wei, M. Hu, Y.-s. Wang, X.-w. Zhang, R. Zhang, L. Zhang, B. Yao, et al. Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs Carcinogenesis, December 1, 2006; 27(12): 2434 - 2441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-S. Lee, J.-H. Kim, K.-J. Choi, I.-K. Choi, H. Kim, S. Cho, B. C. Cho, and C.-O. Yun Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and b7-1 in an immunocompetent murine model. Clin. Cancer Res., October 1, 2006; 12(19): 5859 - 5868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Helguera, J. A. Rodriguez, and M. L. Penichet Cytokines fused to antibodies and their combinations as therapeutic agents against different peritoneal HER2/neu expressing tumors. Mol. Cancer Ther., April 1, 2006; 5(4): 1029 - 1040. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Xian, H. Yang, Y. Lin, and S. Liu Combination Nonviral Murine Interleukin 2 and Interleukin 12 Gene Therapy and Radiotherapy for Head and Neck Squamous Cell Carcinoma Arch Otolaryngol Head Neck Surg, December 1, 2005; 131(12): 1079 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Trudeau, M. M. Cotreau, L. Stonis, K. H. Dykstra, J. L. Oestreicher, A. Strahs, A. J. Dorner, V. H. Van Cleave, W. L. Trepicchio, and U. S. Schwertschlag A Single Administration of Recombinant Human Interleukin-12 Is Associated With Increased Expression Levels of Interferon-gamma and Signal Transducer and Activator of Transcription in Healthy Subjects J. Clin. Pharmacol., June 1, 2005; 45(6): 649 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xu, H. Kurihara, T. Ito, H. Kikuchi, K. Yoshida, H. Yamanokuchi, and A. Asari The Keratan Sulfate Disaccharide Gal(6S03) {beta}1,4-GlcNAc(6S03) Modulates Interleukin 12 Production by Macrophages in Murine Thy-1 Type Autoimmune Disease J. Biol. Chem., May 27, 2005; 280(21): 20879 - 20886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M.L. van Herpen, J. A.W.M. van der Laak, I. J. M. de Vries, J. H. van Krieken, P. C. de Wilde, M. G.J. Balvers, G. J. Adema, and P. H.M. De Mulder Intratumoral Recombinant Human Interleukin-12 Administration in Head and Neck Squamous Cell Carcinoma Patients Modifies Locoregional Lymph Node Architecture and Induces Natural Killer Cell Infiltration in the Primary Tumor Clin. Cancer Res., March 1, 2005; 11(5): 1899 - 1909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Pouniotis, O. Proudfoot, V. Bogdanoska, V. Apostolopoulos, T. Fifis, and M. Plebanski Dendritic Cells Induce Immunity and Long-Lasting Protection against Blood-Stage Malaria despite an In Vitro Parasite-Induced Maturation Defect Infect. Immun., September 1, 2004; 72(9): 5331 - 5339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. van Herpen, M. Looman, M. Zonneveld, N. Scharenborg, P. C. de Wilde, L. van de Locht, M. A. W. Merkx, G. J. Adema, and P. H. De Mulder Intratumoral Administration of Recombinant Human Interleukin 12 in Head and Neck Squamous Cell Carcinoma Patients Elicits a T-Helper 1 Profile in the Locoregional Lymph Nodes Clin. Cancer Res., April 15, 2004; 10(8): 2626 - 2635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Pelloso, K. Cyran, L. Timmons, B. T. Williams, and M. J. Robertson Immunological Consequences of Interleukin 12 Administration after Autologous Stem Cell Transplantation Clin. Cancer Res., March 15, 2004; 10(6): 1935 - 1942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Lambert, C. Y. Okada, and R. Levy TCR Vaccines against a Murine T Cell Lymphoma: A Primary Role for Antibodies of the IgG2c Class in Tumor Protection J. Immunol., January 15, 2004; 172(2): 929 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Bryson, L. Zhang, S. W. Goes, C. D. Jennings, B. E. Caywood, S. L. Carlson, and A. M. Kaplan CD4+ T Cells Mediate Murine Syngeneic Graft-versus-Host Disease-Associated Colitis J. Immunol., January 1, 2004; 172(1): 679 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kimura, H. Mizuno, K. Satake, H. Tahara, and M. Tsukuda Effects of Combined Therapy With Interleukin 2 and Interleukin 12 Gene-Transfected Tumor Vaccine for Head and Neck Carcinoma Arch Otolaryngol Head Neck Surg, November 1, 2003; 129(11): 1181 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Trembleau, G. Penna, S. Gregori, N. Giarratana, and L. Adorini IL-12 Administration Accelerates Autoimmune Diabetes in Both Wild-Type and IFN-{gamma}-Deficient Nonobese Diabetic Mice, Revealing Pathogenic and Protective Effects of IL-12-Induced IFN-{gamma} J. Immunol., June 1, 2003; 170(11): 5491 - 5501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zhang and L. J. DeGroot Gene Therapy of a Rat Follicular Thyroid Carcinoma Model with Adenoviral Vectors Transducing Murine Interleukin-12 Endocrinology, April 1, 2003; 144(4): 1393 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Robertson, D. Pelloso, R. Abonour, R. A. Hromas, R. P. Nelson Jr., L. Wood, and K. Cornetta Interleukin 12 Immunotherapy after Autologous Stem Cell Transplantation for Hematological Malignancies Clin. Cancer Res., November 1, 2002; 8(11): 3383 - 3393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Burdelya, R. Catlett-Falcone, A. Levitzki, F. Cheng, L. B. Mora, E. Sotomayor, D. Coppola, J. Sun, S. Sebti, W. S. Dalton, et al. Combination Therapy with AG-490 and Interleukin 12 Achieves Greater Antitumor Effects than Either Agent Alone Mol. Cancer Ther., September 1, 2002; 1(11): 893 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Shi, A. L. Rakhmilevich, C. P. Heise, K. Oshikawa, P. M. Sondel, N.-S. Yang, and D. M. Mahvi Intratumoral Injection of Interleukin-12 Plasmid DNA, Either Naked or in Complex with Cationic Lipid, Results in Similar Tumor Regression in a Murine Model Mol. Cancer Ther., September 1, 2002; 1(11): 949 - 957. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Segal, N. C. Lee, Y. L. Tsung, J. A. Norton, and K. Tsung The Role of IFN-{gamma} in Rejection of Established Tumors by IL-12 : Source of Production and Target Cancer Res., August 15, 2002; 62(16): 4696 - 4703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Peter, M. J. Brunda, and G. Corradin IL-12 Administration Leads to a Transient Depletion of T Cells, B Cells, and APCs and Concomitant Abrogation of the HLA-A2.1-Restricted CTL Response in Transgenic Mice J. Immunol., July 1, 2002; 169(1): 63 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kelleher and P. C. L. Beverley Lipopolysaccharide Modulation of Dendritic Cells Is Insufficient to Mature Dendritic Cells to Generate CTLs from Naive Polyclonal CD8+ T Cells In Vitro, Whereas CD40 Ligation Is Essential J. Immunol., December 1, 2001; 167(11): 6247 - 6255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Matsumoto, A. Itakura, A. Tanaka, C. Fujisawa, and H. Matsuda Inability of IL-12 to Down-Regulate IgE Synthesis Due to Defective Production of IFN-{gamma} in Atopic NC/Nga Mice J. Immunol., November 15, 2001; 167(10): 5955 - 5962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Trembleau, S. Gregori, G. Penna, I. Gorny, and L. Adorini IL-12 Administration Reveals Diabetogenic T Cells in Genetically Resistant I-E{alpha}-Transgenic Nonobese Diabetic Mice: Resistance to Autoimmune Diabetes Is Associated with Binding of E{alpha}-Derived Peptides to the I-Ag7 Molecule J. Immunol., October 1, 2001; 167(7): 4104 - 4114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Ahlers, I. M. Belyakov, S. Matsui, and J. A. Berzofsky Mechanisms of cytokine synergy essential for vaccine protection against viral challenge Int. Immunol., July 1, 2001; 13(7): 897 - 908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Wiekowski, M. W. Leach, E. W. Evans, L. Sullivan, S.-C. Chen, G. Vassileva, J. F. Bazan, D. M. Gorman, R. A. Kastelein, S. Narula, et al. Ubiquitous Transgenic Expression of the IL-23 Subunit p19 Induces Multiorgan Inflammation, Runting, Infertility, and Premature Death J. Immunol., June 15, 2001; 166(12): 7563 - 7570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Smyth, E. Cretney, K. Takeda, R. H. Wiltrout, L. M. Sedger, N. Kayagaki, H. Yagita, and K. Okumura Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (Trail) Contributes to Interferon {gamma}-Dependent Natural Killer Cell Protection from Tumor Metastasis J. Exp. Med., March 19, 2001; 193(6): 661 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Abe, T. Peng, J. Sailors, R. Bucala, and C. N. Metz Regulation of the CTL Response by Macrophage Migration Inhibitory Factor J. Immunol., January 15, 2001; 166(2): 747 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-y. Wu, X. Wang, M. Gadina, J. J. O'Shea, D. H. Presky, and J. Magram IL-12 Receptor {beta}2 (IL-12R{beta}2)-Deficient Mice Are Defective in IL-12-Mediated Signaling Despite the Presence of High Affinity IL-12 Binding Sites J. Immunol., December 1, 2000; 165(11): 6221 - 6228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Wang, D. A. Frank, and J. Ritz Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4 Blood, May 15, 2000; 95(10): 3183 - 3190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nakamura, T. Otani, Y. Ijiri, R. Motoda, M. Kurimoto, and K. Orita IFN-{gamma}-Dependent and -Independent Mechanisms in Adverse Effects Caused by Concomitant Administration of IL-18 and IL-12 J. Immunol., March 15, 2000; 164(6): 3330 - 3336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Thibodeaux, S. E. Hunter, K. E. Waldburger, J. L. Bliss, W. L. Trepicchio, J. P. Sypek, K. Dunussi-Joannopoulos, S. J. Goldman, and J. P. Leonard Autocrine Regulation of IL-12 Receptor Expression Is Independent of Secondary IFN-{gamma} Secretion and not Restricted to T and NK Cells J. Immunol., November 15, 1999; 163(10): 5257 - 5264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lefrancois, S. Olson, and D. Masopust A Critical Role for Cd40-Cd40 Ligand Interactions in Amplification of the Mucosal Cd8 T Cell Response J. Exp. Med., November 1, 1999; 190(9): 1275 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sturmhoefel, K. Lee, G. S. Gray, J. Thomas, R. Zollner, M. O'Toole, H. Swiniarski, A. Dorner, and S. F. Wolf Potent Activity of Soluble B7-IgG Fusion Proteins in Therapy of Established Tumors and as Vaccine Adjuvant Cancer Res., October 1, 1999; 59(19): 4964 - 4972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Ha, C. H. Lee, S. B. Lee, C. M. Kim, K. L. Jang, H. S. Shin, and Y. C. Sung A Novel Function of IL-12p40 as a Chemotactic Molecule for Macrophages J. Immunol., September 1, 1999; 163(5): 2902 - 2908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. P. Heinzel and R. M. Rerko Cure of Progressive Murine Leishmaniasis: Interleukin 4 Dominance Is Abolished by Transient CD4+ T Cell Depletion and T Helper Cell Type 1-selective Cytokine Therapy J. Exp. Med., June 21, 1999; 189(12): 1895 - 1906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Mullins, C. J. Burger, and K. D. Elgert Paclitaxel Enhances Macrophage IL-12 Production in Tumor-Bearing Hosts Through Nitric Oxide J. Immunol., June 1, 1999; 162(11): 6811 - 6818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Bungiro Jr., M. Goldberg, P. K. Suri, and P. M. Knopf Interleukin-12 as an Adjuvant for an Antischistosome Vaccine Consisting of Adult Worm Antigens: Protection of Rats from Cercarial Challenge Infect. Immun., May 1, 1999; 67(5): 2340 - 2348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Hirschowitz and R. G. Crystal Adenovirus-Mediated Expression of Interleukin-12 Induces Natural Killer Cell Activity and Complements Adenovirus-Directed gp75 Treatment of Melanoma Lung Metastases Am. J. Respir. Cell Mol. Biol., May 1, 1999; 20(5): 935 - 941. [Abstract] [Full Text]
|
|
|
|
|
|
T. Matsushita, K. Ando, K. Kimura, H. Ohnishi, M. Imawari, Y. Muto, and H. Moriwaki IL-12 induces specific cytotoxicity against regenerating hepatocytes in vivo Int. Immunol., May 1, 1999; 11(5): 657 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Curtsinger, C. S. Schmidt, A. Mondino, D. C. Lins, R. M. Kedl, M. K. Jenkins, and M. F. Mescher Inflammatory Cytokines Provide a Third Signal for Activation of Naive CD4+ and CD8+ T Cells J. Immunol., March 15, 1999; 162(6): 3256 - 3262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H. Balkhy and F. P. Heinzel Endotoxin Fails to Induce IFN-{gamma} in Endotoxin-Tolerant Mice: Deficiencies in Both IL-12 Heterodimer Production and IL-12 Responsiveness J. Immunol., March 15, 1999; 162(6): 3633 - 3638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Yao, C. Sgadari, K. Furuke, E. T. Bloom, J. Teruya-Feldstein, and G. Tosato Contribution of Natural Killer Cells to Inhibition of Angiogenesis by Interleukin-12 Blood, March 1, 1999; 93(5): 1612 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Gabaglia, B. Pedersen, M. Hitt, N. Burdin, E. E. Sercarz, F. L. Graham, J. Gauldie, and T. A. Braciak A Single Intramuscular Injection with an Adenovirus- Expressing IL-12 Protects BALB/c Mice Against Leishmania major Infection, While Treatment with an IL-4-Expressing Vector Increases Disease Susceptibility in B10.D2 Mice J. Immunol., January 15, 1999; 162(2): 753 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Car, V. M. Eng, J. M. Lipman, and T. D. Anderson The Toxicology of Interleukin-12: A Review Toxicol Pathol, January 1, 1999; 27(1): 58 - 63. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Robertson, C. Cameron, M. B. Atkins, M. S. Gordon, M. T. Lotze, M. L. Sherman, and J. Ritz Immunological Effects of Interleukin 12 Administered by Bolus Intravenous Injection to Patients with Cancer Clin. Cancer Res., January 1, 1999; 5(1): 9 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. E. Fogler, K. Volker, M. Watanabe, J. M. Wigginton, P. Roessler, M. J. Brunda, J. R. Ortaldo, and R. H. Wiltrout Recruitment of Hepatic NK Cells by IL-12 Is Dependent on IFN-{gamma} and VCAM-1 and Is Rapidly Down-Regulated by a Mechanism Involving T Cells and Expression of Fas J. Immunol., December 1, 1998; 161(11): 6014 - 6021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Collison, S. Saleh, R. Parhar, B. Meyer, A. Kwaasi, K. Al-Hussein, S. Al-Sedairy, and F. Al-Mohanna Evidence for IL-12-Activated Ca2+ and Tyrosine Signaling Pathways in Human Neutrophils J. Immunol., October 1, 1998; 161(7): 3737 - 3745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rosendahl, K. Kristensson, J. Hansson, K. Riesbeck, T. Kalland, and M. Dohlsten Perforin and IFN-{gamma} Are Involved in the Antitumor Effects of Antibody-Targeted Superantigens J. Immunol., June 1, 1998; 160(11): 5309 - 5313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. Siders, P. W. Wright, J. A. Hixon, W. G. Alvord, T. C. Back, R. H. Wiltrout, and R. G. Fenton T Cell- and NK Cell-Independent Inhibition of Hepatic Metastases by Systemic Administration of an IL-12-Expressing Recombinant Adenovirus J. Immunol., June 1, 1998; 160(11): 5465 - 5474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yoshimoto, Y. Takahama, C.-R. Wang, T. Yoneto, S. Waki, and H. Nariuchi A Pathogenic Role of IL-12 in Blood-Stage Murine Malaria Lethal Strain Plasmodium berghei NK65 Infection J. Immunol., June 1, 1998; 160(11): 5500 - 5505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bohn, E. Schmitt, C. Bielfeldt, A. Noll, R. Schulte, and I. B. Autenrieth Ambiguous Role of Interleukin-12 in Yersinia enterocolitica Infection in Susceptible and Resistant Mouse Strains Infect. Immun., May 1, 1998; 66(5): 2213 - 2220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Toda, R. L. Martuza, H. Kojima, and S. D. Rabkin In Situ Cancer Vaccination: An IL-12 Defective Vector/Replication-Competent Herpes Simplex Virus Combination Induces Local and Systemic Antitumor Activity J. Immunol., May 1, 1998; 160(9): 4457 - 4464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, S. P. Li, S. A. Moser, K. L. Bost, and J. E. Domer Cytokine Involvement in Immunomodulatory Activity Affected by Candida albicans Mannan Infect. Immun., April 1, 1998; 66(4): 1384 - 1391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ogasawara, K. Takeda, W. Hashimoto, M. Satoh, R. Okuyama, N. Yanai, M. Obinata, K. Kumagai, H. Takada, H. Hiraide, et al. Involvement of NK1+ T Cells and Their IFN-{gamma} Production in the Generalized Shwartzman Reaction J. Immunol., April 1, 1998; 160(7): 3522 - 3527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yoshimoto, C.-R. Wang, T. Yoneto, S. Waki, S. Sunaga, Y. Komagata, M. Mitsuyama, J.-i. Miyazaki, and H. Nariuchi Reduced T Helper 1 Responses in IL-12 p40 Transgenic Mice J. Immunol., January 15, 1998; 160(2): 588 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Lavigne, L. R. Schopf, C. L. Chung, R. Maylor, and J. P. Sypek The Role of Recombinant Murine IL-12 and IFN-{gamma} in the Pathogenesis of a Murine Systemic Candida albicans Infection J. Immunol., January 1, 1998; 160(1): 284 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bohn, A. Sing, R. Zumbihl, C. Bielfeldt, H. Okamura, M. Kurimoto, J. Heesemann, and I. B. Autenrieth IL-18 (IFN-{gamma}-Inducing Factor) Regulates Early Cytokine Production in, and Promotes Resolution of, Bacterial Infection in Mice J. Immunol., January 1, 1998; 160(1): 299 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ikeda, N. Ohta, K. Furukawa, H. Miyazaki, L. Wang, K. Furukawa, K. Kuribayashi, L. J. Old, and H. Shiku Mutated mitogen-activated protein kinase: A tumor rejection antigen of mouse sarcoma PNAS, June 10, 1997; 94(12): 6375 - 6379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Presky, H. Yang, L. J. Minetti, A. O. Chua, N. Nabavi, C.-Y. Wu, M. K. Gately, and U. Gubler A functional interleukin 12 receptor complex is composed of two beta -type cytokine receptor subunits PNAS, November 26, 1996; 93(24): 14002 - 14007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Robertson and J. Ritz Interleukin 12: Basic Biology and Potential Applications in Cancer Treatment Oncologist, February 1, 1996; 1(1): 88 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Zou, D. S. Schoenhaut, D. M. Carvajal, R. R. Warrier, D. H. Presky, M. K. Gately, and U. Gubler Structure-Function Analysis of the p35 Subunit of Mouse Interleukin 12 J. Biol. Chem., March 17, 1995; 270(11): 5864 - 5871. [Abstract] [Full Text] [PDF]
|
|